Efeito da ingestão de chocolate no desejo por doces e sintomas caracterí­sticos da sí­ndrome da tensão pré-menstrual

Autores

  • Neiva Santos Souza VP Research Institute
  • Nayara Dantas Massunaga VP Research Institute
  • Hannah Médici Scielzo VP Research Institute
  • Renata Alves Carnauba VP Research Institute
  • Ana Beatriz Baptistella VP Research Institute
  • Valéria Paschoal VP Research Institute
  • Andreia Naves VP Research Institute
  • Natália Marques VP Research Institute
  • Gabriel de Carvalho VP Research Institute
  • Daniela Fojo Seixas Chaves USP

DOI:

https://doi.org/10.33233/nb.v16i5.745

Resumo

mudanças no comportamento alimentar, que estão associados com o desejo de comer alimentos altamente palatáveis. Embora não haja uma relação causal clara, existe uma associação entre o desejo excessivo de chocolate e as mudanças hormonais do ciclo menstrual. Examinamos o efeito dos consumos de chocolate de leite e chocolate com maior teor de cacau (50%) adicionado de fibras no desejo por doces e sintomas de sí­ndrome de tensão pré-menstrual em 19 participantes. Este estudo experimental aberto durou 2 ciclos menstruais, incluindo fase de controle (fase I) com ingestão de chocolate de leite (50 g/dia) e fase de intervenção (fase II) com o consumo de chocolate 50% cacau com fibras adicionadas (50 g/dia) durante a fase lútea de cada ciclo. Os sintomas de sí­ndrome de tensão pré-menstrual foram classificados por escala validada. A intervenção com de chocolate 50% cacau com fibras adicionadas, comparada com o baseline e controle com chocolate ao leite, mostrou uma redução nos sintomas fí­sicos (p = 0,0206), e tanto os perí­odos de intervenção como os de controle mostraram mudanças nos padrões alimentares (p = 0,0012), como redução do desejo por doces, chocolates entre outros.

Palavras-chave: sí­ndrome de tensão pré-menstrual, sí­ndrome pré-menstrual, cacau, chocolate, compulsão alimentar, serotonina.

Biografia do Autor

Daniela Fojo Seixas Chaves, USP

Department of Food and Experimental Nutrition, School of Pharmaceutical Sciences of the University of Sao Paulo

Referências

Pediatr Adolesc Gynecol 2007;20:3-12.

Freeman EW. Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis. Psychoneuroendocrinology 2003;28(3):25-37.

Freeman EW, Halberstadt EM, Rickels K et al. Core symptoms that discriminate premenstrual syndrome. J Womens Health 2011;20:29-35.

Direkvand-Moghadam A, Sayehmiri K, Delpisheh A, Kaikhavandi S. Epidemiology of premenstrual syndrome (PMS) – a systematic review and meta-analysis. J Clin Diagn Res 2015;8(2):106-9.

Klump KL, Keel PL, Culbert KM, Elder C. Ovarian hormones and binge eating: exploring associations in community samples. Psychol Med 2008;38(12):1749-57.

Edler C, Lipson SF, Keel PK. Ovarian hormones and binge eating in bulimia nervosa. Psychol Med 2007;37(1):131-41.

Martin CK, O’neil PM, White MA. The association between food cravings and consumption of specific foods in a laboratory taste test. Appetite 2008;51(2):324-6.

Zellner DA, Garriga-Trillo A, Centeno S, Wadsworth E. Chocolate craving and the menstrual cycle. Appetite 2004;42(1):119-21.

Brown SG, Morrison LA, Calibuso MJ, Christiansen TM. The menstrual cycle and sexual behavior: relationship to eating, exercise, sleep and health patterns. Women Health 2008;48(4):429-44. doi: 10.1080/03630240802575179.

Russo S, Kema IP, Fokkema MR et al. Tryptophan as a link between psychopathology and somatic states. Psychosom Med 2003;65(4):665-71.

Widner B, Laich A, Sperner-Unterweger B et al. Neopterin production tryptophan degradation and mental depression: what is the link? Brain Behav Immun 2002;16:590-5.

Dantzer R, O’connor JC, Freund GG et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.

Jenney M, Santer E, Klein A et al. Cacao extracts suppress tryptophan degradation of mitogen-stimulated peripheral blood mononuclear cells. J Ethnopharmacol 2009;122:261-7.

Steiner M, Peer M, Macdougall M et al. The premenstrual tension syndrome rating scales: An updated version. J Affect Disord 2011;135:82-8.

Budeiri DJ, Li Wan PA, Dornan JC. Clinical trials of treatments of premenstrual syndrome: entry criteria and scales for measuring treatment outcomes. Br J Obstet Gynaecol 1994;101(8):689-95.

Fernstrom JD. Large neutral amino acids: dietary effects on brain neurochemistry and function. Amino Acids 2013;45(3):419-30.

Fernstrom JD, Langham KA, Marcelino LM et al. The ingestion of different dietary proteins by humans induces large changes in the plasma tryptophan ratio, a predictor of brain tryptophan uptake and serotonin synthesis. Clin Nutr 2013; 32(6):1073-6.

Hiemke C, Härtter D. Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 2000;85(1):11-28.

Voigt JP, Fink H. Serotonin controlling feeding and satiety. Behav Brain Res 2015;77:14-31.

Steiner M, Wilkins A. Diagnosis and assessment of premenstrual dysphoria. Psychiatr Ann 1996;26:571-5.

Abraham GE. The premenstrual tension syndrome rating scales: An updated version. J Reprod Med 1983;28(7):446-64.

Padmavathi P. Effect of acupressure vs. reflexology on pre menstrual syndrome among adolescent girls – a pilot study. Nurs J India 2014;105(5):236-9.

Yonkers KA, O´Brein PM, Eriksson E et al. Premenstrual syndrome. Lancet 2008;371:1200-10.

TadakawA M, Takeda T, Momma Y et al. The prevalence and risk factors of school absenteeism due to premenstrual disorders in Japanese high school students-a school-based cross-sectional study. Biopsychosoc Med 2016;26:10-3.

Imai A, Ichigo S, Matsunami K et al. Premenstrual syndrome: management and pathophysiology. Clin Exp Obstet Gynecol 2015;42(2):123-8.

Rapkin AJ, Akopians AL. Pathophysiology of premenstrual syndrome and premenstrual dysphoric disorder. Menopause Int 2012;18(2):52-9.

Nabavi SM, Daglia M, Braidy N, Nabavi SF. Natural products, micronutrientes, and nutraceuticals for the treatment of depression: a short review. Nutr Neurosci 2017;20(3):180-94. doi: 10.1080/1028415X.2015.1103461

Rogers PJ, Smit HJ. Food craving and food addiction: a critical review of the evidence from a biopsychosocial perspective. Pharmacol Biochem Behav 2000;66(1):3-14.

Yamada T, Yamada Y, Okano Y et al. Anxiolytic effects of short-and long-term administration of cacao mass on rat elevated T-maze test. J Nutr Biochem 2009;20(12):948-55.

Wang L, Nagele T, Doerfler H et al. System level analysis of cacao seed ripening reveals a sequential interplay of primary and secondary metabolism leading to polyphenol accumulation and preparation of stress resistance. Plant J 2016;;87(3):318-32. doi: 10.1111/tpj.13201

Becker K, Geisler S, Ueberall F et al. Immunomodulatory properties of cacao extracts – potential consequences for medical applications. Front Pharmacol 2013;4:154.

Mauskop A, Varughese J. Why all migraine patients should be treated with magnesium. J Neural Transm 2012;119(5):575-9.

Nooh AM, Abdul-Hady A, El-Attar N. Nature and prevalence of menstrual disorders among teenage female students at Zagazig University, Zagazig Egypt. J Pediatr Adolesc Gynecol 2016;29(2):137-42.

Backstrom T, Haage D, Lofgren M et al. Paradoxical effects of GABA-A modulators may explain sex steroid induced negative mood symptoms in some persons. Neuroscience 2011;191:46-54.

Hantsoo L, Epperson CN. Premenstrual dysphoric disorder: epidemiology and treatment. Curr Psychiatry Rep 2015;17(11):87.

McFarlin BK, Venable AS, Henning AL et al. Natural cocoa consumption: potential to reduce atherogenic factors? J Nutr Biochem 2015;26(6):626-32.

Matsumoto C, Petrone AB, Sesso HD et al. Chocolate consumption and risk of diabetes mellitus in the physicians´s health study. Am J Clin Nutr 2015;101(2):362-7.

Niu L, Han DW, Xu RL et al. A high sugar high-fat diet induced metabolic syndrome shows some symptoms of Alzheimer´s disease in rats. J Nutr Health Aging 2016;20(5):509-13.

Downloads

Publicado

2017-12-28

Edição

Seção

Artigos originais